Advertisement

Dialysis Encephalopathy

Questions and Answers
  • D. N. S. Kerr
  • M. K. Ward
  • I. S. Parkinson

Abstract

In this chapter we address ourselves to the questions in Table 1, as a means of reviewing the current state of knowledge about dialysis encephalopathy and of suggesting areas for further research.

Keywords

Chronic Renal Failure Dialysis Fluid Serum Aluminum Osteitis Fibrosa Dialysis Encephalopathy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Alfrey AC, Mishell JM, Burks J, Contiguglia SR, Rudolph H, Lewin E, Holmes JH: Syndrome of dyspraxia and multifocal seizures associated with chronic hemodialysis. Transactions. Am Soc Artif Intern Organs 18:257–261, 1972.Google Scholar
  2. 2.
    Barratt LJ, Lawrence JR: Dialysis-associated dementia. Aust New Zeal J Med 5:62–65, 1975.PubMedGoogle Scholar
  3. 3.
    Bone I: Progressive dialysis encephalopathy: “Dialysis dementia,” in Davison AM (ed): Dialysis Review. Tunbridge Wells, Pitman, 1978, pp 216–229.Google Scholar
  4. 4.
    Burks JS, Alfrey AC, Huddlestone J, Norenberg MD, Lewin E: A fatal encephalopathy in chronic haemodialysis patients. Lancet 1:764–768, 1976.PubMedGoogle Scholar
  5. 5.
    Chokroverty S, Bruetman ME, Berger V, Reyes, MG: Progressive dialytic encephalopathy. J Neurol Neurosurg Psychiatr 39:411–419, 1976.PubMedGoogle Scholar
  6. 6.
    Kerr DNS: Clinical and pathologic changes in patients on chronic dialysis: The central nervous system, in Hamburger J, Crosnier J, Grünefeld J-P, Maxwell MH (eds): Advances in Nephrology, Vol 9. Chicago, Year Book, 1980, pp 109–132.Google Scholar
  7. 7.
    Mahurkar SD, Dhar SK, Salta R, Meyers L, Smith EC, Dunea G: Dialysis dementia. Lancet 1:1412–1415, 1973.PubMedGoogle Scholar
  8. 8.
    Mahurkar SD, Smith EC, Mamdani BH, Dunea G: Dialysis dementia—the Chicago experience. J Dialysis 2:447–458, 1978.Google Scholar
  9. 9.
    Nadel AM, Wilson WP: Dialysis encephalopathy: A possible seizure disorder. Neurology 26:1130–1134, 1976.PubMedGoogle Scholar
  10. 10.
    Ward MK, Feest TG: Dialysis encephalopathy, in Anderton JL, Parsons FM, Jones DE: Living with Renal Failure. Lancaster, MTP Press, 1978, pp 123–133.Google Scholar
  11. 11.
    Ward MK, Pierides AM, Fawcett P, Shaw DA, Perry RH, Tomlinson BE, Kerr DNS: Dialysis encephalopathy syndrome. Proc Eur Dial Transpl Assoc 13:348–354, 1976.Google Scholar
  12. 11a.
    Galle P, Chatel M, Berry JP, Menault F: Encephalopathie progressive des dialysés: Preésence d’aluminium en forte concentration dans les lysosomes des cellules cérébrales. Nouv Presse Med 8:4091–4094, 1979.PubMedGoogle Scholar
  13. 12.
    English A, Savage RD, Britton PG, Ward MK, Kerr DNS: Intellectual impairment in chronic renal failure. Br Med J 1:880–890, 1978.Google Scholar
  14. 13.
    Ackrill P, Barron J, Whiteley S, Horn AC, Ralston AJ: A new approach to the early detection of dialysis encephalopathy. Proc Eur Dial Transpl Assoc 16:659–660, 1979.Google Scholar
  15. 14.
    Alfrey AC, LeGendre GR, Kaehny WD: The dialysis encephalopathy syndrome. Possible aluminium intoxication. N Engl J Med 294:184–188, 1976.PubMedGoogle Scholar
  16. 15.
    McDermott JR, Smith AI, Ward MK, Parkinson IS, Kerr DNS: Brain-aluminium concentration in dialysis encephalopathy. Lancet 1:901–904, 1978.PubMedGoogle Scholar
  17. 16.
    Carder F, Allain P, Gary J, Chatel M, Menault F, Pecker S: Encéphalopathie myoctonique progressive des dialysés. Rôle de l’eau utilisée pour l’hémodialyse. Nouv Presse Méd 7:97–102, 1978.Google Scholar
  18. 17.
    Flendrig JA, Kruis HK, Das HA: Aluminium intoxication: The cause of dialysis dementia? Proc Eur Dialy Transpl Assoc 13:355–361, 1976.Google Scholar
  19. 18.
    Platts MM, Hislop JS: Aluminium and dialysis encephalopathy. Lancet 2:98, 1976.PubMedGoogle Scholar
  20. 19.
    Pascoe MD, Gregory MC: Dialysis encephalopathy: Aluminum concentration in dialysate and brain. Kidney Int 16:90, 1979.Google Scholar
  21. 20.
    Parkinson IS, Ward MK, Feest TG, Fawcett RWP, Kerr DNS: Fracturing dialysis osteodystrophy and dialysis encephalopathy: An epidemiological survey. Lancet 1:406–409, 1979.PubMedGoogle Scholar
  22. 21.
    Platts MM, Moorhead PJ, Grech P: Dialysis dementia. Lancet 2:159, 1973.Google Scholar
  23. 22.
    Platts MM, Goode GC, Hislop JS: Composition of the domestic water supply and the incidence of fractures and encephalopathy in patients on home dialysis. Br Med J 2:657–660, 1977.PubMedGoogle Scholar
  24. 23.
    Masramon J, Ricart MJ, Caralps A, Lloveras J, Andreu J, Brulles A, Sola R: Dialysis encephalopathy. Lancet 1:1370, 1978.PubMedGoogle Scholar
  25. 24.
    Ward MK, Feest TG, Ellis HA, Parkinson IS, Kerr DNS, Herrington J, Goode GL: Osteomalacic dialysis osteodystrophy: Evidence for a water-borne aetiological agent, probably aluminium. Lancet 1:841–845, 1978.PubMedGoogle Scholar
  26. 25.
    Hudson G, Milne J, Reis P, Meyer AM, Hayward A: Renal osteodystrophy in regular hemodialysis patients using softened or deionized water. Kidney Int 16:87, 1979.Google Scholar
  27. 26.
    Alfrey AC, Hegg A, Miller N, Berl T, Berns A: Interrelationship between calcium and aluminium metabolism in dialyzed uremic patients. Mineral Electrolyte Metab 2:81–87, 1979.Google Scholar
  28. 27.
    Cournot-Witner G, Zingraff J, Bourdon R, Drueke T, Balsan S: Aluminium and dialysis bone disease. Lancet 2:795–796, 1979.Google Scholar
  29. 28.
    Ellis HA, McCarthy JH, Herrington J: Bone aluminium in haemodialysed patients and in rats injected with aluminium chloride: Relationship to impaired bone mineralisation. J Clin Pathol 32:832–844, 1979.PubMedGoogle Scholar
  30. 29.
    Elluott HL, Dryburgh F, Fell GS, Sabet S, MacDougall AI: Aluminium toxicity during regular haemodialysis. Br Med J 1:1101–1103, 1978.Google Scholar
  31. 30.
    Jacobs C, Brunner FP, Chantier C, Donckerwolcke RA, Gurland HJ, Hathway RA, Selwood NH, Wing AJ: Combined report on regular dialysis and transplantation in Europe VII, 1976. Proc Eur Dial Transpl Assoc 14:3–67, 1977.Google Scholar
  32. 31.
    Berkseth R, Mahowald M, Anderson D, Shapiro F: Dialysis encephalopathy: Diagnostic criteria and epidemiology of 39 patients. Kidney Int 14:670, 1978.Google Scholar
  33. 32.
    Rozas VV, Port FK, Easterling RD: An outbreak of dialysis dementia due to aluminium in the dialysate. J Dialysis 2:459–470, 1978.Google Scholar
  34. 33.
    Rozas VV, Port FK, Rutt WM: Progressive dialysis encephalopathy from dialysate aluminum. Arch Intern Med 138:1375–1377, 1978.PubMedGoogle Scholar
  35. 34.
    Schreeder MT: Dialysis encephalopathy. Arch Intern Med 139:510–511, 1979.PubMedGoogle Scholar
  36. 35.
    McKinney TD, Dewberry FL, Stone WJ, Alfrey AC: Dialysis dementia at the Nashville Veterans Administration Hospital. Kidney Int 14:680, 1978.Google Scholar
  37. 36.
    Kaehny WD, Alfrey AC, Holman RD, Shorr WJ: Aluminum transfer during hemodialysis. Kidney Int 12:361–365, 1977.PubMedGoogle Scholar
  38. 37.
    Allain P, Thebaud HE, Dupouet L, Coville P, Pissant M, Spiesser J, Alquier P: Étude des taux sanguins de quelques métaux (Al, Mn, Cd, Pb, Cu, Zn) chez les hémodialysés chroniques avant et aprés dialyse. Nouv Presse Méd 7:92–96, 1978.PubMedGoogle Scholar
  39. 38.
    Salvadeo A, Minoia C, Segnagni S, Villa G: Trace metal changes in dialysis fluid and blood of patients on hemodialysis. Int J Artificial Organs 2:17–21, 1979.Google Scholar
  40. 39.
    Graf H, Stummvoll HK, Meisinger V, Kovarik J, Wolf A, Pingerra WF: Aluminium in haemodialysis. Lancet 1:379, 1979.PubMedGoogle Scholar
  41. 40.
    Gacek EM, Babb AL, Uvelli DA, Fry DL, Scribner BH: Dialysis dementia: The role of dialysate pH in altering the dialyzability of aluminum. Trans Am Soc Artif Intern Organs, 25:409–415, 1979.PubMedGoogle Scholar
  42. 41.
    Parkinson IS, Beckett A, Ward MK, Feest TG, Hoenich N, Strong A, Kerr DNS: Aluminium: Removal from water supplies. Proc Eur Dial Transpl Assoc 15:586–587, 1978.Google Scholar
  43. 42.
    Kaehny WD, Hegg AP, Alfrey AC: Gastrointestinal absorption of aluminum from aluminum-containing antacids. N Engl J Med 296:1389–1390, 1977.PubMedGoogle Scholar
  44. 43.
    Marsden SNE, Parkinson IS, Ward MK, Ellis HA, Kerr DNS: Evidence of aluminium accumulation in renal failure. Proc Eur Dial Transpl Assoc 16:588–594, 1979.Google Scholar
  45. 44.
    Boukari M, Rottembourg J, Jaudon MC, Clavel JP, Legrain M, Galli A: Influence de la prise prolongée de gels d’alumine sur les tauz sériques d’aluminium chez les patients atteints d’insufficance rénale chronique. Nouv Presse Méd 7:85–88, 1978.PubMedGoogle Scholar
  46. 45.
    Zumkley H, Bertram HP, Lison A, Knoll O, Losse H: Aluminium, zinc and copper concentrations in plasma in chronic renal insufficiency. Clin Nephrol 12:18–21, 1979.PubMedGoogle Scholar
  47. 46.
    Kovalchik MT, Kaehny WD, Hegg AP, Jackson JT, Alfrey AC: Aluminum kinetics during hemodialysis. J Lab Clin Med 92:712–720, 1978.PubMedGoogle Scholar
  48. 47.
    Mehta RP: Encephalopathy in chronic renal failure appearing before the start of dialysis. Can Med Assoc J 120:1112–1114, 1979.PubMedGoogle Scholar
  49. 48.
    Buge A, Poisson M, Masson S, Bleibel JM, Mashaly R, Jaudon MC, Lafforgue B, Lebkin B, Raymond P: Encephalopathie réversible des dialysés après arrêt de l’apport d’aluminium. Nouv Presse Méd 8:2729–2733, 1979.PubMedGoogle Scholar
  50. 49.
    Eade OA, Krawitt EL, Grice D, Wright R, Trowell J: Reversible dialysis encephalopathy: Role for aluminium-containing gels. Lancet 2:1386–1387, 1978.Google Scholar
  51. 50.
    Silke B, Fitzgerald GGR, Hanson S, Carmody M, O’Dwyer, WF: Dialysis dementia and renal transplantation. Dialysis Transplant 7:486–487, 1978.Google Scholar
  52. 51.
    Sullivan PA, Murnaghan DJ, Callaghan N: Dialysis dementia: Recovery after renal transplantation. Br Med J 2:740–741, 1977.PubMedGoogle Scholar
  53. 52.
    Pierides AM: Dialysis dementia, osteomalacic fractures and myopathy: A syndrome due to chronic aluminum intoxication. Int J Artificial Organs 1:206–208, 1978.Google Scholar
  54. 53.
    Pierides AM, Edwards W, Cullum U, Ellis HA: An epidemic of the haemodialysis encephalopathy, myopathy and fracture syndrome in Columbia, SC, USA, in Abstracts 7th International Congress of Nephrology, Montreal, ISN, 1978, p S–13.Google Scholar
  55. 54.
    Poisson M, Mashaly R, Lebkiri B: Dialysis encephalopathy: Recovery after interruption of aluminium intake. Br Med J 2:1610–1611, 1978.PubMedGoogle Scholar
  56. 55.
    Berkseth RO, Anderson DC, Mahowald MW, Shapiro F: Dialysis encephalopathy: Effects of continued aluminum exposure and clonazepam on prognosis. Kidney Int 14:670, 1978.Google Scholar
  57. 56.
    Mayor GH, Keiser JA, Makdani D, Ku PK: Aluminum absorption and distribution: Effect of parathyroid hormone. Science 197:1187–1189, 1977.PubMedGoogle Scholar
  58. 57.
    Mayor GH, Kesier JA, Sanchez TV, Sprague SM, Hook JB: Factors affecting tissue aluminum concentration. J Dialysis 2:471–481, 1978.Google Scholar
  59. 58.
    Noordewier B, Commissaris RL, Cordon J, Keiser JA, Mayor GH, Rech RH: Effect of chronic oral aluminium administration on shuttlebox avoidance behavior in rats. Kidney Int 14:682, 1978.Google Scholar
  60. 59.
    Sprague SM, Sanchez TV, Hourani MR, Keiser JA, Mayor GH: Egress of aluminum from rat brain following withdrawal of parathyroid hormone, in Abstracts 7th International Congress of Nephrology, Montreal, ISN, 1978, p S–18.Google Scholar
  61. 60.
    Ball JH, Butkus DE, Madison DS: Effect of subtotal parathyroidectomy on dialysis dementia. Nephron 18:151–155, 1975.Google Scholar
  62. 61.
    Mahoney CA, Arieff AI: Uremic encephalopathies: Clinical, biochemical and experimental features. Am J Kidney Dis 2:324–336, 1982.PubMedGoogle Scholar
  63. 62.
    Rotundo A, Nevins TE, Lipton M, Lockman LA, Mauer SM, Michael AF: Progressive encephalopathy in children with chronic renal insufficiency in infancy. Kidney Int 21:486–491, 1982.PubMedGoogle Scholar
  64. 63.
    Parkinson IS, Ward MK, Kerr DNS: Dialysis encephalopathy, bone disease and anaemia: The aluminium intoxication syndrome during regular haemodialysis. J Clin Pathol 34:1285–1294, 1981.PubMedGoogle Scholar
  65. 64.
    Wills MR, Savory J: Aluminium poisoning: Dialysis encephalopathy, osteomalacia, and anaemia. Lancet 2:29–34, 1983.PubMedGoogle Scholar
  66. 65.
    Leather HM, Lewin IG, Calder E, Braybrooke J, Cox RR: Effect of water deionisers on “fracturing osteodystrophy” and dialysis encephalopathy in Plymouth. Nephron 29:80–84, 1981.PubMedGoogle Scholar
  67. 66.
    Davison AM, Walker GS, Oli H, Lewins AM: Water supply aluminium concentration, dialysis dementia and effect of reverse-osmosis water treatment. Lancet 2:785–787, 1982.PubMedGoogle Scholar
  68. 67.
    Martin de Francisco AL, Fernandez MD, Ordoñez R, Alvarez C, Cotorruelo JG, Arias M, Sousa F, Llamarares y C: El aluminio en la insuficiencia renal crónica, hemodialysis y trasplante renal. Nefrologia 3:95–107, 1983.Google Scholar
  69. 68.
    Platts MM, Anastassiades E: Dialysis encephalopathy; Precipitating factors and improvement in prognosis. Clin Nephrol 15:223–228, 1981.PubMedGoogle Scholar
  70. 69.
    Galle P, Giudicelli CP: Toxicité de l’aluminium pour l’hépatocyte. Localisation ultrastructurale et micro-analyse des dépôts. Nouv Presse Med 11:1123–1125, 1982.PubMedGoogle Scholar
  71. 70.
    Henry DA, Nudelman RK, Didomenico NC, Stanley TM, Alfrey AC, Goodman WG, Slatopolsky E, Coburn JW: Metabolic and toxic effects of aluminum in the dog. Kidney Int 21:229, 1982. (abstr).Google Scholar
  72. 71.
    Chan Y-L, Alfrey AC, Posen S, Lissner D, Hills E, Dunstan CR, Evans RA: Effect of aluminium on normal and uremic rats: Tissue distribution, Vitamin D metabolites, and quantitative bone histology. Calcif Tissue Int 35:344–351, 1983.PubMedGoogle Scholar
  73. 72.
    Robertson JA, Felsenfeld AJ, Haywood CC, Wilson P, Clarke C, LLach F: Animal model of aluminum-induced osteomalacia: Role of chronic renal failure. Kidney Int 23:327–335, 1983.PubMedGoogle Scholar
  74. 73.
    Goodman WG, Gilligan J, Horst R: Short-term aluminum administration in the rat. Effects on bone formation and relationship to renal osteomalacia. J Clin Invest 73:171–181, 1984.PubMedGoogle Scholar
  75. 74.
    Dewberry FL, McKinney TD, Stone WJ: The dialysis dementia syndrome: report of fourteen cases and review of the literature. Asaio J 3:102–108, 1980.Google Scholar
  76. 75.
    McKinney TD, Basinger M, Dawson E, Jones MM: Serum aluminum levels in dialysis dementia. Nephron 32:53–56, 1982.PubMedGoogle Scholar
  77. 76.
    Platts MM, Owen G, Smith S: Water purification and the incidence of fractures in patients receiving home haemodialysis supervised by a single centre; evidence for “safe” upper limit of aluminum in water. Br Med J 288:969–972, 1984.Google Scholar
  78. 77.
    Fleming LW, Stewart WK, Fell GS, Halls DJ: The effect of oral aluminium therapy on plasma aluminium levels in patients with chronic renal failure in an area with low water aluminium. Clin Nephrol 17:222–227, 1982.PubMedGoogle Scholar
  79. 78.
    Biswas CK, Arze RS, Ramos JM, Ward MK, Dewar JH, Kerr DNS, Kenward DH: Effect of aluminium hydroxide on serum ionised calcium, immunoreactive parathyroid hormone, and aluminium in chronic renal failure. Br Med J 284:776–778, 1982.Google Scholar
  80. 79.
    Moriniere Ph, Roussel A, Tahiri Y, de Fremont JF, Maurel G, Jaudon MC, Gueris J, Fournier A: Substitution of aluminium hydroxide by high doses of calcium carbonate in patients on chronic haemodialysis: Disappearance of hyperaluminaemia and equal control of hyperparathyroidism. Proc. Eur Dial Transpl Assoc 19:784–787, 1982.Google Scholar
  81. 80.
    Schneider H, Kulbe KD, Weber H, Streicher E: High-effective aluminium free phosphate binder. In vitro and in vivo studies. Proc. Eur Dial Transpl Assoc 20:725–729, 1983.Google Scholar
  82. 81.
    Mittal VK, Sharma MJ, Toledo-Pereyra LH, Baskin S, McNichol LJ: Complete recovery from dialysis dementia following kidney transplantation. Dial Transpl 10(No 1):41–42, 1981.Google Scholar
  83. 82.
    O’Hare JA, Callaghan NM, Murnaghan DJ: Dialysis encephalopathy. Clinical, electroencephalographic and interventional aspects. Medicine 62:129–141, 1983.PubMedGoogle Scholar
  84. 83.
    Graf H, Stummvoll HK, Meisinger V, Kovarik J, Wolf A, Pingerra WF: Aluminum removal by hemodialysis. Kidney Int 19:587–592, 1981.PubMedGoogle Scholar
  85. 84.
    Graf H, Stummvoll HK, Meisinger V: Desferrioxamine-induced changes of aluminium kinetics during haemodialysis. Proc Eur Dial Transpl Assoc 18:674–680, 1981.Google Scholar
  86. 85.
    Ackrill P, Ralston AJ, Day JP, Hodge KC: Successful removal of aluminium from patient with dialysis encephalopathy. Lancet 2:692–693, 1980.PubMedGoogle Scholar
  87. 86.
    Arze RS, Parkinson IS, Cartlidge NEF, Britton P, Ward MK: Reversal of aluminium dialysis encephalopathy after desferrioxamine treatment. Lancet 2:1116, 1981.PubMedGoogle Scholar
  88. 87.
    Pogglitsch H, Petek W, Wawschinek O, Holzer W: Treatment of early stages of dialysis encephalopathy by aluminium depletion. Lancet 2:1344–1355, 1981.PubMedGoogle Scholar
  89. 88.
    Milne FJ, Sharf B, Bell P, Meyers AM: The effect of low aluminum water and desferrioxamine on the outcome of dialysis encephalopathy. Clin Nephrol 20:202–207, 1983.PubMedGoogle Scholar
  90. 89.
    Bugiani O, Bernardino G: Progressing encephalomyelopathy with muscular atrophy, induced by aluminum powder. Neurobiol Aging 3:209–222, 1982.PubMedGoogle Scholar
  91. 90.
    Wisniewski HM, Sturman JA, Shek JW: Chronic model of neurofibrillary changes induced in mature rabbits by metallic aluminum. Neurobiol Aging 3:11–22, 1982.PubMedGoogle Scholar
  92. 91.
    Crapper McLachlan DR, Dam T-V, Farnell BJ, Lewis PN: Aluminum inhibition of ADP-ribosylation in vivo and in vitro. Neurobehav Toxicol Teratol 5:645–647, 1983.Google Scholar
  93. 92.
    Lai JCK, Blass JP: Inhibition of brain glycolysis by aluminum. J Neurochem 42:438–446, 1984.PubMedGoogle Scholar
  94. 93.
    Banks WA, Kastin AJ: Aluminium increases permeability of the blood-brain barrier to labelled DSIP and B-endorphin: Possible implications for senile and dialysis dementia. Lancet 2:1227–1229, 1983.PubMedGoogle Scholar
  95. 94.
    Siegel N, Suhayda C, Haug A: Aluminum changes the conformation of calmodulin. Physiol Chem Phys 14:165–167, 1982.PubMedGoogle Scholar
  96. 95.
    Siegel N, Haug A, Aluminum interaction with calmodulin. Evidence for altered structure and function from optical and enzymatic studies. Biochim Biophys Acta 744:36–45, 1983.PubMedGoogle Scholar
  97. 96.
    Mayor GH, Sprague SM, Sanchez TV: Determinants of tissue aluminum concentration. Am J Kidney Dis 1:141–145, 1981.PubMedGoogle Scholar
  98. 97.
    Morrissey J, Rothstein M, Mayor G, Slatopolsky E: Suppression of parathyroid secretion by aluminum. Kidney Int 23:699–704, 1983.PubMedGoogle Scholar
  99. 98.
    Robertson JA, Felsenfeld AJ, Haygood CC, Wilson P, Clarke C, Llach F: Animal model of aluminum-induced osteomalacia; Role of chronic renal failure. Kidney Int 23:327–335, 1983.PubMedGoogle Scholar
  100. 99.
    Andress D, Felsenfeld AJ, Voigts A, Llach F: Parathyroid hormone response to hypocalcemia in hemodialysis patients with osteomalacia. Kidney Int 24:364–370, 1983.PubMedGoogle Scholar
  101. 100.
    Kraut JA, Shinaberger JH, Singer FR, Sherrard DJ, Saxton J, Miller JH, Kurokawa K, Coburn JW: Parathyroid gland unresponsiveness to acute hypocalcemia in dialysis osteomalacia. Kidney Int 23:725–733, 1983.PubMedGoogle Scholar
  102. 101.
    Campbell PGC, Bisson M, Bougie R, Tessier A, Villeneuve J-P: Speciation of aluminum in acidic freshwater. Anal Chem 55:2246–2252, 1983.Google Scholar
  103. 102.
    Pierides AM, Frohnert PP, Sharbrough FW: Release of aluminum by the Redy dialysis cartridge. Osteomalacia and dialysis encaphalopathy after prolonged usage. Blood Purification 1:145–153, 1983.Google Scholar
  104. 103.
    Shapiro WB, Schilb TP, Waltrous CL, Levy SR, Porush JG: Aluminum leakage from REDY sorbent cartridge. Kidney Int 23:536–539, 1983.PubMedGoogle Scholar
  105. 104.
    Odell RA, Yang J, George CR, Farrell PC: Aluminum kinetics during sorbent (Redy) dialysis. Contemporary Dialysis, pp 57–62, July 1982.Google Scholar

Copyright information

© Plenum Publishing Corporation 1985

Authors and Affiliations

  • D. N. S. Kerr
    • 1
  • M. K. Ward
    • 2
  • I. S. Parkinson
    • 3
  1. 1.Royal Postgraduate Medical SchoolHammersmith HospitalLondonEngland
  2. 2.Department of MedicineRoyal Victoria InfirmaryNewcastle upon TyneEngland
  3. 3.Department of Clinical BiochemistryRoyal Victoria InfirmaryNewcastle upon TyneEngland

Personalised recommendations